Feldman, David
Funk, Luke http://orcid.org/0000-0002-3901-4691
Le, Anna
Carlson, Rebecca J. http://orcid.org/0000-0002-5423-9717
Leiken, Michael D.
Tsai, FuNien
Soong, Brian http://orcid.org/0000-0003-4647-7704
Singh, Avtar
Blainey, Paul C. http://orcid.org/0000-0002-4889-8783
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (HG006193)
Article History
Received: 26 March 2021
Accepted: 28 October 2021
First Online: 12 January 2022
Competing interests
: P.C.B. is a consultant to and/or equity holder in companies in the life sciences industries, including 10X Genomics, GALT, Celsius Therapeutics, Next Generation Diagnostics, Cache DNA and Concerto Biosciences. P.C.B.’s laboratory receives research funding from Calico Life Sciences and Merck for work related to genetic screening. The Broad Institute and MIT have filed US patent applications on work described here and may seek to license the technology.